Brief: Avid Bioservices Completes Construction Of New Cell And Gene Therapy Development And Manufacturing Facility
17/10/2023 13:57
Oct 17 (Reuters) - Avid Bioservices Inc CDMO.O :
* AVID BIOSERVICES COMPLETES CONSTRUCTION OF NEW,
WORLD-CLASS CELL
AND GENE THERAPY DEVELOPMENT AND MANUFACTURING FACILITY
* AVID BIOSERVICES INC - COMPLETION OF CGT FACILITY BRINGS
CO'S
TOTAL REVENUE GENERATING CAPACITY TO UP TO ABOUT $400 MILLION
ANNUALLY
Source text for Eikon: ID:nGNX1BCrlt
Further company coverage: CDMO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avid Bioservices
See all newsBrief: Avid Bioservices Recommends Stockholders Vote For Value Maximizing Transaction
Avid Bioservices Inc reports results for the quarter ended October 31 - Earnings Summary
U.S. RESEARCH ROUNDUP- Autozone, Costco Wholesale, Salesforce
Press Digest: Wall Street Journal - Nov. 7
Brief: Avid Bioservices to be acquired for $1.1 bln by GHO Capital Partners, Ampersand Capital Partners